Charts
18 Apr, 2024
17 Apr, 2024
16 Apr, 2024
15 Apr, 2024
12 Apr, 2024
11:48
Seeking Alpha
11 Apr, 2024
10 Apr, 2024
09 Apr, 2024
08 Apr, 2024
News
04 Apr, 2024
Here is how Adverum Biotechnologies (ADVM) and Cigna (CI) have performed compared to their sector so far this year.
Adverum (ADVM) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
03 Apr, 2024
13:35
Yahoo! Finance
The heavy selling pressure might have exhausted for Adverum Biotechnologies (ADVM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
27 Mar, 2024
13:35
Yahoo! Finance
The heavy selling pressure might have exhausted for Adverum Biotechnologies (ADVM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
21 Mar, 2024
20 Mar, 2024
18:03
FinancialContent
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it ...
09:33
Yahoo! Finance
ADVM Announces Q4 and Full Year 2023 Results with Strategic Clinical and Corporate Developments
19 Mar, 2024
Here is how Adverum Biotechnologies (ADVM) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
ADVM stock results show that Adverum Biotechnologies beat analyst estimates for earnings per share the fourth quarter of 2023.
The post ADVM Stock Earnings: Adverum Biotechnologies Beats EPS for Q4 2023 appeared first on InvestorPlace.
More From InvestorPlace
The #1 AI Investment Might Be This Company You’ve Never Heard Of
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
It doesn’t matter if you have $500 or $5 million. Do this now.
18 Mar, 2024
20:05
Yahoo! Finance
- Preliminary LUNA data presented at the Annual Meeting of the Macula Society support potential best-in-class clinical activity and an encouraging safety profile in patients with wet AMD - - Completed $127.5 million private placement financing with new and existing institutional investors - - Cash runway expected into late 2025 – - 1-for-10 reverse stock split to be effective March 21, 2024 - REDWOOD CITY, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a
06 Mar, 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
There are plenty of penny stocks ready to pop but we have to remember that penny stocks are extremely risky, too.
The post Turn Pocket Change into Profit: 3 Penny Stocks Ready to Pop appeared first on InvestorPlace.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
It doesn’t matter if you have $500 or $5 million. Do this now.
04 Mar, 2024
28 Feb, 2024
21:05
Yahoo! Finance
REDWOOD CITY, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that Laurent Fischer, M.D., president and chief executive officer of Adverum Biotechnologies, will participate in the Ophthalmology Corporate Panel Discussion at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5th, 2024 at 9:10 a.m. ET. The
27 Feb, 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Navigate the bullish trend in the market by wagering on these three enticing market sensations likely to become multi-bagger investments
The post Stocks on the Launchpad: The Next 3 Market Sensations appeared first on InvestorPlace.
More From InvestorPlace
The #1 AI Investment Might Be This Company You’ve Never Heard Of
“America’s Top Trader” Issues A.I. Code Red: Act Now or Miss Out
It doesn’t matter if you have $500 or $5 million. Do this now.
22 Feb, 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Our economy is doing well, and these top penny stocks are in position to benefit from this. Invest now and see strong returns.
The post Unleash Massive Returns With These 3 Top Penny Stocks appeared first on InvestorPlace.
More From InvestorPlace
The #1 AI Investment Might Be This Company You’ve Never Heard Of
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
12 Feb, 2024
13:00
Yahoo! Finance
REDWOOD CITY, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that Laurent Fischer, M.D., president and chief executive officer of Adverum Biotechnologies, will present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference on Tuesday, February 13th, 2024 at 12:00 p.m. ET. The on-demand webcast corporate p
08 Feb, 2024
Adverum Biotechnologies Inc(NASDAQ:ADVM) released preliminary safety and efficacy data from the ongoing LUNA Phase 2 trial in ...
12:00
Yahoo! Finance
– Both dose levels (2E11 & 6E10) demonstrate potential best-in-class clinical activity in hard-to-treat patients including treatment burden reduction and maintenance of both visual acuity and anatomic endpoints – – Preliminary safety data support a favorable benefit-risk profile at both dose levels – – Ozurdex + difluprednate identified as potential “go-forward” prophylaxis – – The vast majority of patients on the “go-forward” regimen had no inflammation and >90% of patients have no or minimal i
05 Feb, 2024
In trading on Monday, biotechnology shares were relative leaders, up on the day by about 0.2%. Leading the group were shares of 4D Molecular Therapeutics, up about 73.3% and shares of Adverum Biotechnologies up about 31.7% on the day.
17:56
FinancialContent
Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported ...
Gainers
4D Molecular Therapeutics (NASDAQ:FDMT) stock increased by 75.2% to $30.64 during Monday's regular session. The company's ...
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) shares are trading higher Monday after the company announced that it has agreed to sell ...
Gainers
4D Molecular Therapeutics (NASDAQ:FDMT) stock rose 60.1% to $28.0 during Monday's pre-market session. The market value of their ...
- Financing led by TCGX with participation from new and existing investors including 5AM Ventures, Commodore Capital, Frazier Life Sciences, Logos Capital, Samsara BioCapital, Venrock Healthcare Capital Partners and Vivo Capital, as well two large investment management firms. - Pro forma cash and investments expected to fund current operating plan into late 2025. REDWOOD CITY, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that ai
01 Feb, 2024
22:30
Yahoo! Finance
- Preliminary safety and efficacy data from ongoing LUNA Phase 2 study of Ixo-vec for the treatment of wet AMD will be presented at the 47th Annual Meeting of the Macula Society, with company-sponsored webcast on Thursday, February 8, 2024 at 8:00am ET - REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced th
29 Jan, 2024
13:00
Yahoo! Finance
REDWOOD CITY, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that Romuald “Romu” Corbau, Ph.D., has joined Adverum as the company’s chief scientific officer. Dr. Corbau will serve as a member of Adverum’s executive committee. “On behalf of the entire team at Adverum, I am delighted to welcome Dr. Corbau as the newest
04 Jan, 2024
Here, we discuss some reasons why buying Adverum Biotechnologies (AQST) stock now may turn out to be a prudent move.
07 Dec, 2023
21:05
Yahoo! Finance
REDWOOD CITY, Calif., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced the initial LUNA preliminary efficacy and safety data will be presented at the upcoming 47th Annual Meeting of the Macula Society, being held February 7 – 10, 2024. “We are very pleased to have the opportunity to present our initial Phase 2 efficacy and saf
28 Nov, 2023
21:05
Yahoo! Finance
REDWOOD CITY, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that Linda Rubinstein, chief financial officer, and Star Seyedkazemi, chief development officer of Adverum Biotechnologies, will participate in a fireside chat at the Evercore ISI 6th Annual HealthCONx Conference on Wednesday, November 29, 2023 at 3:50 p.m.
09 Nov, 2023
21:05
Yahoo! Finance
- Announced preliminary aflibercept protein levels from the on-going Phase 2 LUNA trial, suggesting that both doses are within the therapeutically active range and consistent with aflibercept levels observed in the OPTIC trial - - Reported OPTIC long-term follow-up data demonstrating that patients continue to experience substantial, long-term benefit from Ixo-vec through 3 years of follow-up - - Initial Phase 2 LUNA efficacy and safety data anticipated in Q4 2023 - - Cash runway projected into 2
06 Nov, 2023
Adverum Biotechnologies Inc(NASDAQ: ADVM) revealed updated data from the OPTIC extension study of ixoberogene soroparvovec ...
23 Aug, 2023
21 Aug, 2023
11 Aug, 2023
12 Jun, 2023
13:25
FinancialContent
The Dow Jones closed higher by over 40 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern ...
25 May, 2023
Gainers
Sonnet BioTherapeutics (NASDAQ:SONN) shares moved upwards by 46.3% to $0.42 during Thursday's regular session. The current ...
11 May, 2023
31 Mar, 2023
07 Mar, 2023
Upgrades
Craig-Hallum upgraded the previous rating for Carrols Restaurant Group Inc (NASDAQ:TAST) from Hold to Buy. In the fourth ...
28 Nov, 2022
Gainers
Kala Pharmaceuticals (NASDAQ:KALA) stock rose 24.8% to $7.09 during Monday's after-market session. This security traded at a ...
10 Nov, 2022
26 Oct, 2022
Gainers
Ensysce Biosciences (NASDAQ:ENSC) stock increased by 47.9% to $0.31 during Wednesday's pre-market session. The ...
14 Sep, 2022
The U.S. Food and Drug Administration (FDA) has granted fast track designation for the development of TRACON’s (NASDAQ: TCON) ...
Adverum Biotechnologies (NASDAQ: ADVM) dosed first subject in the LUNA Phase 2 trial evaluating ixoberogene soroparvovec (Ixo-vec, ...
26 Aug, 2022
Gainers
Baudax Bio (NASDAQ:BXRX) shares moved upwards by 58.3% to $0.89 during Friday's pre-market session. The ...
11 Aug, 2022
18 Jul, 2022
Gainers
United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on ...
15 Jul, 2022
Gainers
United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced ...
Adverum Biotechnologies Inc(NASDAQ: ADVM)announced new datafrom the OPTIC study of ADVM-022 for wet age-related ...
13:03
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
NexImmune ReceivesIND ...
07 Jul, 2022
Upgrades
For Pacific Premier Bancorp Inc (NASDAQ:PPBI), Raymond James upgraded the previous rating of Outperform to Strong Buy. In the ...
14:03
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Merck's Potential Buyout ...
Adverum Biotechnologies Inc(NASDAQ: ADVM)announced a restructuring plan, including reductions in headcount and expenses, ...
11:26
FinancialContent
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Good morning, trader! We're taking a look at the biggest pre-market stock movers for Thursday that investors need to know about!
The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace.
More From InvestorPlace
$200 Oil Sooner Than You Think – Buy This Now
The Best $1 Investment You Can Make Today
Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
It doesn’t matter if you have $500 in savings or $5 million. Do this now.
06 Jul, 2022
Gainers
AcelRx Pharmaceuticals (NASDAQ:ACRX) stock increased by 38.9% to $0.36 during Wednesday's after-market session. AcelRx ...
15 Jun, 2022
On Tuesday, shares of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) experienced volatile short activity. After the activity, the stock ...
09 Jun, 2022
07 Jun, 2022
12:31
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Veru Files Emergency Use ...
18 May, 2022
12:11
FinancialContent
Adverum Biotechnologies Inc(NASDAQ: ADVM)has shared new datafrom the ADVM-022 development program in wet ...
12 May, 2022
02 May, 2022
10:59
FinancialContent
Adverum Biotechnologies Inc(NASDAQ: ADVM) announced the presentation of anew post-hoc analysisfrom the OPTIC study ...
25 Apr, 2022
US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or ...
21 Apr, 2022
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
20 Apr, 2022
On Wednesday, 160 companies hit new 52-week lows.
Areas of Significance In Today's 52-Week Lows:
Walt Disney ...
12 Apr, 2022
11:22
FinancialContent
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Good morning! It's time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday!
The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace.
More From InvestorPlace
Stock Prodigy Who Found NIO at $2… Says Buy THIS
It doesn’t matter if you have $500 in savings or $5 million. Do this now.
10 Stocks Are Issuing Sell Signals
Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
07 Apr, 2022
12:24
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
AstraZeneca In-Licenses ...
11:30
FinancialContent
Adverum Biotechnologies Inc(NASDAQ: ADVM) received feedback via aType C meeting written responsefrom the FDA regarding ...
06 Apr, 2022
29 Mar, 2022
07 Feb, 2022
05 Jan, 2022
03 Jan, 2022
21 Dec, 2021
Adverum Biotechnologies Inc(NASDAQ: ADVM)plans to conduct a Phase 2 trialof ADVM-022 in wet AMD at 2 X 10^11 vg/eye ...
04 Nov, 2021
01 Nov, 2021
Investors in Adverum Biotechnologies Inc (ADVM) saw new options begin trading this week, for the November 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ADVM options chain for the new November 19th contracts and identified the following call contract of particular interest.
08 Oct, 2021
11:31
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting ...
07 Oct, 2021
12:23
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting ...
05 Oct, 2021
Gainers
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares climbed 101.9% to close at $31.50 on Monday after the company announced ...
04 Oct, 2021
18:31
FinancialContent
Toward the end of trading Monday, the Dow traded down 1.09% to 33,951.17 while the NASDAQ fell 2.28% to 14,234.17. The S&P also ...
Gainers
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares jumped 71.1% to $26.69 after the company announced its phase 2 study of ...
01 Oct, 2021
05 Aug, 2021
23 Jul, 2021
22 Jul, 2021
24 Jun, 2021
11 May, 2021
06 May, 2021
